| Literature DB >> 25098731 |
Li Bin1, Du Luping2, Sun Bing2, Yu Zhengyu1, Liu Maojun1, Feng Zhixin1, Wei Yanna1, Wang Haiyan1, Shao Guoqing1, He Kongwang1.
Abstract
Mycoplasma hyopneumoniae is considered the major causative agent of porcine respiratory disease complex, occurs worldwide and causes major economic losses to the pig industry. To gain more insights into the pathogenesis of this organism, the high throughput cDNA microarray assays were employed to evaluate host responses of porcine alveolar macrophages to M. hyopneumoniae infection. A total of 1033 and 1235 differentially expressed genes were identified in porcine alveolar macrophages in responses to exposure to M. hyopneumoniae at 6 and 15 hours post infection, respectively. The differentially expressed genes were involved in many vital functional classes, including inflammatory response, immune response, apoptosis, cell adhesion, defense response, signal transduction, protein folding, protein ubiquitination and so on. The pathway analysis demonstrated that the most significant pathways were the chemokine signaling pathway, Toll-like receptor signaling pathway, RIG-I-like receptor signaling pathway, nucleotide-binding oligomerization domains (Nod)-like receptor signaling pathway and apoptosis signaling pathway. The reliability of the data obtained from the microarray was verified by performing quantitative real-time PCR. The expression kinetics of chemokines was further analyzed. The present study is the first to document the response of porcine alveolar macrophages to M. hyopneumoniae infection. The data further developed our understanding of the molecular pathogenesis of M. hyopneumoniae.Entities:
Mesh:
Year: 2014 PMID: 25098731 PMCID: PMC4123846 DOI: 10.1371/journal.pone.0101968
Source DB: PubMed Journal: PLoS One ISSN: 1932-6203 Impact factor: 3.240
Figure 1Clustering and characterization of the differential expression of genes.
(A) The DE genes showing clear functional annotation at 6 HPI have been selected for cluster analysis which is described in methods. Each row represents a separate gene, and each column represents a experiment sample. Color legend is on the left, the color scale ranges from saturated green for log ratios −3.0 and above to saturated red for log ratios 3.0 and above. Red indicates increased gene expression levels; green indicates decreased levels compared with normal samples. (B) Categories of annotated genes based on biological process GO term at 6 HPI. (C) The genes showing clear functional annotation at 15 HPI have been selected for cluster analysis. (D) Categories of annotated genes based on biological process GO term at 15 HPI.
Validation of microarray results by qRT-PCR.
| GenBank ID | Gene symbol | Primers sequence (5′-3′) | Regulation | Microarray FC | Real-time PCR FC |
| NM_214055 | IL1β | F: | up | 41.07 | 56.25 |
| R: | |||||
| NM_213867 | IL8 | F: | up | 4.16 | 8.26 |
| R: | |||||
| NM_214194 | CD40 | F: | up | 2.08 | 4.23 |
| R: | |||||
| NM_001164511 | BCL2A1 | F: | up | 4.15 | 8.95 |
| R: | |||||
| NM_214022 | TNF-α | F: | up | 6.88 | 10.79 |
| R: | |||||
| NM_001110425 | CD302 | F: | down | 2.48 | 3.25 |
| R: | |||||
| NM_001206441 | TAP2 | F: | up | 2.16 | 2.03 |
| R: | |||||
| NM_001113707 | SLA | F: | down | 3.01 | 2.85 |
| R: | |||||
| NM_214162 | CASP1 | F: | down | 2.1 | 6.71 |
| R: | |||||
| NM_001204769 | NLRX1 | F: | down | 2.11 | 5.32 |
| R: | |||||
| NM_213779 | CCL4 | F: | |||
| R: | |||||
| NM_001164515 | CCL8 | F: | |||
| R: | |||||
| NM_001001861 | CXCL2 | F: | |||
| R: | |||||
| NM_001008691 | CXCL10 | F: | |||
| R | |||||
| GAPDH | F: | ||||
| R: |
*Fold change.
The DE genes associated with immune and inflammatory responses at 6 hpi.
| SEQ_ID | p-value | FC Change | GeneName | description |
| NM_213779 | 0.000298 | 52.12223 | CCL4 | Sus scrofa chemokine (C-C motif) ligand 4 (CCL4), mRNA. |
| NM_214055 | 0.000173 | 41.07524 | IL1B | Sus scrofa interleukin 1, beta (IL1B), mRNA. |
| NM_214029 | 0.001527 | 20.72427 | IL1A | Sus scrofa interleukin 1, alpha (IL1A), mRNA. |
| NM_214214 | 0.000228 | 13.97029 | CCL2 | Sus scrofa chemokine (C-C motif) ligand 2 (CCL2), mRNA. |
| NM_001128469 | 0.0000129 | 13.800437 | ISG15 | Sus scrofa ISG15 ubiquitin-like modifier (ISG15), mRNA. |
| NM_001164515 | 0.000172 | 12.3193 | CCL8 | Sus scrofa chemokine (C-C motif) ligand 8 (CCL8), mRNA. |
| NM_001161434 | 7.71E-05 | 10.32473 | LOC780407 | Sus scrofa chemokine ligand 24-like protein (LOC780407), mRNA. |
| NM_001001861 | 0.000775 | 10.01722 | CXCL2 | Sus scrofa chemokine (C-X-C motif) ligand 2 (CXCL2), mRNA. |
| NM_001146128 | 0.008214 | 8.429539 | IL7R | Sus scrofa interleukin 7 receptor (IL7R), mRNA. |
| ENSSSCT0000 0013077 | 0.000562 | 7.193156 | NFKBIZ | Sus scrofa chromosome 13 Sscrofa10.2 partial sequence 165990981..166988044 reannotated via EnsEMBL |
| NM_214084 | 0.003889 | 7.036763 | VEGFA | Sus scrofa vascular endothelial growth factor A (VEGFA), mRNA. |
| NM_214022 | 0.00066 | 6.881882 | TNF | Sus scrofa tumor necrosis factor (TNF), mRNA. |
| XM_001929223 | 6.41E-05 | 6.076357 | PNP | PREDICTED: Sus scrofa purine nucleoside phosphorylase (PNP), mRNA. |
| NM_214061 | 0.000237 | 5.901434 | MX1 | Sus scrofa myxovirus (influenza virus) resistance 1, interferon-inducible protein p78 (mouse) (MX1), mRNA. |
| NM_001008691 | 0.007205 | 5.879376 | CXCL10 | Sus scrofa chemokine (C-X-C motif) ligand 10 (CXCL10), mRNA. |
| NM_001100194 | 0.011522 | 5.642215 | IFIH1 | Sus scrofa interferon induced with helicase C domain 1 (IFIH1), mRNA. |
| NM_001160271 | 1.18E-05 | 5.595223 | S100A8 | Sus scrofa S100 calcium binding protein A8 (S100A8), mRNA. |
| XM_001925952 | 0.002127 | 4.301922 | IFIT5 | PREDICTED: Sus scrofa interferon-induced protein with tetratricopeptide repeats 5 (IFIT5), mRNA. |
| NM_213867 | 0.000619 | 4.162192 | IL8 | Sus scrofa interleukin 8 (IL8), mRNA. |
| NM_001164511 | 0.000316 | 4.145637 | BCL2A1 | Sus scrofa BCL2-related protein A1 (BCL2A1), mRNA. |
| NM_001048232 | 0.000114 | 4.033666 | NFKB1 | Sus scrofa nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (NFKB1), mRNA. |
| NM_001044552 | 5.65E-05 | 3.686546 | LOC733 603 | Sus scrofa serum amyloid A2 (LOC733603), mRNA. |
| NM_214303 | 4.32E-06 | 3.381383 | OAS1 | Sus scrofa 2′-5′-oligoadenylate synthetase 1, 40/46kDa (OAS1), mRNA. |
| XM_003127915 | 0.009899 | 3.04153 | IFI44 | PREDICTED: Sus scrofa interferon-induced protein 44 (IFI44), mRNA. |
| NM_001031796 | 0.000513 | 2.980078 | OAS2 | Sus scrofa 2′-5′-oligoadenylate synthetase 2, 69/71kDa (OAS2), mRNA. |
| XM_001924787 | 0.00041 | 2.957249 | LOC1001 57000 | PREDICTED: Sus scrofa chromosome 6 open reading frame 4, transcript variant 1 (LOC100157000), mRNA. |
| NM_001097416 | 0.012537 | 2.864776 | MX2 | Sus scrofa myxovirus (influenza virus) resistance 2 (mouse) (MX2), mRNA. |
| NM_001097445 | 0.000273 | 2.848918 | CD14 | Sus scrofa CD14 molecule (CD14), mRNA. |
| NM_001005150 | 2.73E-05 | 2.829609 | NFKBIA | Sus scrofa nuclear factor of kappa light polypeptide gene enhancer in B-cells inhibitor, alpha (NFKBIA), mRNA. |
| NM_001177906 | 0.001647 | 2.748172 | S100A9 | Sus scrofa S100 calcium binding protein A9 (S100A9), mRNA. |
| NM_214379 | 0.006056 | 2.74367 | PPARG | Sus scrofa peroxisome proliferator-activated receptor gamma (PPARG), mRNA. |
| NM_001244354 | 0.026452 | 2.451839 | SEC61A1 | Sus scrofa Sec61 alpha 1 subunit (S. cerevisiae) (SEC61A1), mRNA. |
| NM_001033011 | 0.008059 | 2.327992 | FCGR1A | Sus scrofa Fc fragment of IgG, high affinity Ia, receptor (CD64) (FCGR1A), mRNA. |
| NM_001243435 | 0.025967 | 2.307106 | ADORA3 | Sus scrofa adenosine A3 receptor (ADORA3), transcript variant 1, mRNA. |
| NM_213761 | 0.016065 | 2.221215 | TLR2 | Sus scrofa toll-like receptor 2 (TLR2), mRNA. |
| AM177151 | 0.03376 | 2.168304 | LOC1001 25542 | Sus scrofa partial VDJ heavy chain gene for immunoglobulin heavy chain variable region, clone Pig3 CD5+ C13. |
| NM_214194 | 0.004432 | 2.082431 | CD40 | Sus scrofa CD40 molecule, TNF receptor superfamily member 5 (CD40), mRNA. |
| XM_003122031 | 0.001052 | 2.061163 | TRIM14 | PREDICTED: Sus scrofa tripartite motif containing 14 (TRIM14), mRNA. |
| NM_001078667 | 0.01484 | 2.051649 | PSEN1 | Sus scrofa presenilin 1 (PSEN1), mRNA. |
| AM177169 | 0.034076 | 2.033368 | LOC100 125541 | Sus scrofa partial VDJ heavy chain gene for immunoglobulin heavy chain variable region, clone Pig3 CD5- F12. |
| NM_001160272 | 6.64E-05 | 2.027732 | S100A12 | Sus scrofa S100 calcium binding protein A12 (S100A12), mRNA. |
| AF248289 | 0.048925 | 2.001558 | LOC100 037926 | Sus scrofa clone 3 immunoglobulin heavy chain mRNA, partial cds. |
DE genes analysis base on KEGG at 6 hpi.
| Pathway Name | Number | Gene |
| Cytokine-cytokine receptor interaction | 15 | CCL2, CCL3L1, CCL4, CD40, CXCL10, CXCR4, IFNAR2, IL10RB, IL18, IL1A, IL1B, IL1R2, IL7R, IL8, TNF |
| Chemokine signaling pathway | 13 | CCL2, CCL3L1, CCL4, CCL8, CRK, CXCL10, CXCL2, CXCL2, CXCR4, IL8, NFKB1, NFKBIA, SRC |
| RIG-I-like receptor signaling pathway | 11 | CASP10, CXCL10, DHX58, IFIH1, IL8, IRF3, ISG15, NFKB1, NFKBIA, TANK, TNF |
| Toll-like receptor signaling pathway | 11 | CD14, CD40, CXCL10, IFNAR2, IL1B, IL8, IRF3, NFKB1, NFKBIA, TLR2, TNF |
| NOD-like receptor signaling pathway | 8 | CCL2, IL18, IL1B, IL8, NFKB1, NFKBIA, TNF, TNFAIP3 |
| Phagosome | 8 | ATP6V1B2, C1R, CALR, CD14, FCGR1A, OLR1, SEC61A1, TLR2 |
| Apoptosis | 7 | BIRC3, CASP10, IL1A, IL1B, NFKB1, NFKBIA, TNF |
| Cell adhesion molecules | 7 | CD274, CD40, CLDN4, CLDN7, ITGB8, SDC4, VCAM1 |
| Jak-STAT signaling pathway | 7 | IFNAR2, IL10RB,IL7R, MYC, PIAS2, SOCS1, SOCS7 |
| PPAR signaling pathway | 6 | ACSL1, ACSL4, ACSL5, GK, OLR1, PPARG |
Figure 2STRING analysis of the relationship between DE genes.
The DE genes in PAM cells infected M. hyopneumoniae were analyzed using the STRING database. The network nodes represent the proteins encoded by the DE genes. Seven different colored lines link a number of nodes and represent seven types of evidence used in predicting associations. A red line indicates the presence of fusion evidence; a green line represents neighborhood evidence; a blue line represents coocurrence evidence; a purple line represents experimental evidence; a yellow line represents textmining evidence; a light blue line represents database evidence and a black line represents co-expression evidence.
Figure 3Expression kinetics of chemokines in PAM.
PAMs were mock-infected, infected with M. hyopneumoniae. Cells were collected at the indicated time points, and subjected to real-time PCR to analyze the expression of CCL4 (A), CCL8 (B), CXCL2 (C) and CXCL10 (D).